These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


268 related items for PubMed ID: 28376844

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
    Marhadour S, Marchand P, Pagniez F, Bazin MA, Picot C, Lozach O, Ruchaud S, Antoine M, Meijer L, Rachidi N, Le Pape P.
    Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP, Abrahim-Vieira BA, Domingos TFS, de Jesus JB, de Sousa ACC, Rodrigues CR, Souza AMT.
    Eur J Med Chem; 2018 Apr 25; 150():920-929. PubMed ID: 29602038
    [Abstract] [Full Text] [Related]

  • 8. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
    Sirajuddin M, Ali S, McKee V, Sohail M, Pasha H.
    Eur J Med Chem; 2014 Sep 12; 84():343-63. PubMed ID: 25036793
    [Abstract] [Full Text] [Related]

  • 9. A Schmidt rearrangement-mediated synthesis of novel tetrahydro-benzo[1,4]diazepin-5-ones as potential anticancer and antiprotozoal agents.
    Insuasty D, Robledo SM, Vélez ID, Cuervo P, Insuasty B, Quiroga J, Nogueras M, Cobo J, Abonia R.
    Eur J Med Chem; 2017 Dec 01; 141():567-583. PubMed ID: 29102177
    [Abstract] [Full Text] [Related]

  • 10. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents.
    Azad I, Nasibullah M, Khan T, Hassan F, Akhter Y.
    J Mol Graph Model; 2018 May 01; 81():211-228. PubMed ID: 29609141
    [Abstract] [Full Text] [Related]

  • 11. 2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro.
    Rodrigues KA, Dias CN, Néris PL, Rocha Jda C, Scotti MT, Scotti L, Mascarenhas SR, Veras RC, de Medeiros IA, Keesen Tde S, de Oliveira TB, de Lima Mdo C, Balliano TL, de Aquino TM, de Moura RO, Mendonça Junior FJ, de Oliveira MR.
    Eur J Med Chem; 2015 Dec 01; 106():1-14. PubMed ID: 26513640
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antileishmanial activity of polycyclic derivatives.
    Sarciron ME, Terreux R, Prieto Y, Cortes M, Cuellar MA, Tapia RA, Domard M, Walchshofer N, Pétavy AF.
    Parasite; 2005 Sep 01; 12(3):251-8. PubMed ID: 16218213
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of novel quinoline-based 4,5-dihydro-1H-pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents.
    Ramírez-Prada J, Robledo SM, Vélez ID, Crespo MDP, Quiroga J, Abonia R, Montoya A, Svetaz L, Zacchino S, Insuasty B.
    Eur J Med Chem; 2017 May 05; 131():237-254. PubMed ID: 28329730
    [Abstract] [Full Text] [Related]

  • 16. Synthesis, cytotoxicity, and in vitro antileishmanial activity of mono-t-butyloxycarbonyl-protected diamines.
    Pinheiro AC, Rocha MN, Nogueira PM, Nogueira TC, Jasmim LF, de Souza MV, Soares RP.
    Diagn Microbiol Infect Dis; 2011 Nov 05; 71(3):273-8. PubMed ID: 21907525
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.